Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEAVO study
ISRCTN13623634Phase 3Completed
- Sponsor
- Moorfields Eye Hospital
- Start
- Dec 2014
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics, Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised trial in central retinal vein occlusion (CRVO) comparing Aflibercept arm, Bevacizumab arm and Ranibizumab arm (3 arms). Started Dec 2014; status: completed.
02
Drugs
afliberceptbevacizumabranibizumab
03
Conditions
central retinal vein occlusion (CRVO)
Beyond the preview
Go deeper on ISRCTN13623634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13623634.